To investigate the importance of this signalling molecule, we next blocked IL‐6 and WNT5A signalling as well as Cdc42‐GTPase activation itself in BRAFi‐R melanoma cells and studied how these treatments affected the cellular actin network. The gene discussed is CDC42; the disease is melanoma.